10-hydoxy camptothecin self micro emulsifieation composition

A hydroxycamptothecin, self-microemulsion technology, applied in the directions of drug combination, emulsion delivery, capsule delivery, etc., can solve the problems of loss of pharmacological activity, reduced anticancer activity, large toxic and side effects, etc., to increase blood circulation time, Toxicity reduction, thermodynamic stabilization effect

Inactive Publication Date: 2005-08-10
FUDAN UNIV
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main problems of the drug are: short half-life (5min-1h), repeated administration is required, so the side effects are relatively large; fat solubility is strong, and the anticancer activity of the water-soluble sodium salt is reduced by 90%; poor stability , the lactone ring of the drug is sensitive to li...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 10-hydoxy camptothecin self micro emulsifieation composition
  • 10-hydoxy camptothecin self micro emulsifieation composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Dissolve 2 g of 10-hydroxycamptothecin in 1000 ml of polyethylene glycol-200, add 1000 ml of polyoxyethylene castor oil (Cremophor EL), 2500 ml of isopropyl myristate, and mix well.

Embodiment 2

[0020] Dissolve 2 g of 10-hydroxycamptothecin in 1000 ml of propylene glycol, add 500 ml of polyoxyethylene castor oil (Cremophor EL), 500 g of soybean lecithin, and 2500 ml of isopropyl myristate, and mix well.

Embodiment 3

[0022] Dissolve 2 g of 10-hydroxycamptothecin in 1000 ml of glycerin, add 500 ml of polyethylene glycol-8-glycerol caprylic acid / capric acid ester (Labrasol), 500 ml of Tween-80, 1000 ml of caprylic triglyceride, linoleic acid Glyceride 1000ml, mix well.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A self-microemulsifying 10-hydroxycamptothecine composition applied by injection or orally features that its self-microemulsifier is prepared from oil phase, surfactant and cosurfactant. After it is taken into human body, it can automatically microemulsifying for higher biologic utilization rate.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to a 10-hydroxycamptothecin self-microemulsion composition and a preparation method thereof. Background technique [0002] 10-hydroxycamptothecin (Hydrocamptothecin, HCPT) is a trace alkaloid with the strongest anti-cancer effect among similar anti-tumor monomers extracted from camphor tree chinensis in the 1960s and 1970s. It is an S-phase specific anti-cancer drug . Systematic pharmacological research. Its anti-cancer mechanism is to inhibit Topo I. It is mainly used clinically in ascites-type liver cancer, head and neck cancer, gastric cancer, bladder cancer and leukemia. The toxic reactions of HCPT are mainly manifested in the inhibition of urinary system, digestive system and hematopoietic function. etc., but its toxicity is significantly lower than that of camptothecin, especially the urinary system reaction is less, and it is easy to be accepted clinically. At prese...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/107A61K9/48A61K9/70A61K31/475A61P35/00
Inventor 施斌裴元英
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products